Study questions dioxin’s link to cancer

	Tweet

Findings from a study of Dow Chemical workers suggest that exposure to dioxin may not increase the risk for certain cancers, as is widely believed.

Compared with deaths in the general U.S. population, researchers found no higher deaths from all cancers, and specifically from lung cancers and non-malignant lung disease, among pesticide plant workers exposed to dioxin over 36 years on average.

Dr. James J. Collins, an epidemiologist at Dow Chemical Company in Midland, Michigan, and colleagues assessed the health effects from long term workplace exposures to the dioxin, 2,3,7,8-tetrachlorodibenzo-p-dioxin. 

This form of dioxin, commonly called TCDD, is listed as a known human carcinogen by the International Agency for Research on Cancer, Collins and colleagues note in a report in the American Journal of Epidemiology.

The 1,615 workers studied had estimated body levels of dioxins “much higher” than estimated levels from environmental exposures in the general population, Collins noted in an email correspondence to Reuters Health.

Yet, outside of a potentially greater risk of a highly malignant soft-tissue sarcoma reported in 4 workers, there were no more cancer deaths among exposed workers than among the general population.

The investigation did reveal slightly more deaths from diabetes, heart disease, leukemia, and a cancer of the lymph nodes called non-Hodgkin lymphoma among TCDD-exposed workers compared with the general population. But Collins’ group observed no trend linking these deaths with dioxin exposures.

Despite hundreds of human studies on the potential health effects of dioxins, “there is still no scientific consensus on the potential for health effects related to dioxin,” Collins said.

Therefore, “further studies, especially those which measure dioxin body levels, would be prudent,” he concluded.

By Joene Hendry
SOURCE: American Journal of Epidemiology, August 15, 2009

RELATED STORIES:
New era in cancer prevention   Deleted Genes Help Predict Outcome in a Children’s Cancer   Mistletoe extract may treat bladder cancer   Mount Sinai researchers discover possible new target for sarcoma treatment and prevention   Cancer Drug Aids an Anti-Cancer Virus   Enzyme Test for Bladder Cancer May Promote Early Diagnosis   Cancer Cases and Deaths are preventable   Surgical technique relieves painful spine fractures in patients with metastatic cancer   Cancer patients want honesty, compassion from their oncologist   Women underrepresented in most cancer research   Identifying subsets of patients who will respond to subsequent lines of chemotherapy   New Combination Therapy that Promotes Cancer Cell Death   Olive oil may hinder cancer process   Drug combination boosts survival rate in head and neck cancers   Terminal cancer patients do not receive appropriate radiation therapy   Nicotine interferes with chemotherapy, study finds   Farmers’ kids at risk for Ewing’s sarcoma   Mechanism for invasion of tumorous cells discovered by Hebrew University researchers   Cancer centers and high-volume hospitals may examine more lymph nodes in cancer patients   Children could be saved from neuroblastoma using antibody therapy   Researchers find environmentally friendly ways to produce more Taxol   1 disease, not 1 demographic

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]